Literature DB >> 24684214

Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS): Is there a correct answer?

Keith S Heller1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24684214     DOI： 10.1089/thy.2014.0142

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  3 in total

Review 1.  Core Needle Biopsy of the Thyroid: 2016 Consensus Statement and Recommendations from Korean Society of Thyroid Radiology.

Authors:  Dong Gyu Na; Jung Hwan Baek; So Lyung Jung; Ji-Hoon Kim; Jin Yong Sung; Kyu Sun Kim; Jeong Hyun Lee; Jung Hee Shin; Yoon Jung Choi; Eun Ju Ha; Hyun Kyung Lim; Soo Jin Kim; Soo Yeon Hahn; Kwang Hwi Lee; Young Jun Choi; Inyoung Youn; Young Joong Kim; Hye Shin Ahn; Ji Hwa Ryu; Seon Mi Baek; Jung Suk Sim; Chan Kwon Jung; Joon Hyung Lee
Journal:  Korean J Radiol       Date:  2017-01-05       Impact factor: 3.500

2.  The Risk Stratification of Papillary Thyroid Cancer With Bethesda Category III (Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance) by Thyroid Fine-Needle Aspiration Could Be Assisted by Tumor Size for Precision Treatment.

Authors:  Xiaojuan Zha; Zhenchun Miao; Xiu Huang; Xingchun Wang; Ruting Xie; Jiaoying Jin; Dajin Zou; Peng Yang; Yueye Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-07       Impact factor: 5.555

3.  Rate of malignancy for thyroid nodules with AUS/FLUS cytopathology in a tertiary care center - a retrospective cohort study.

Authors:  Kalpesh Hathi; Tarek Rahmeh; Vicki Munro; Victoria Northrup; Ali Sherazi; Christopher J Chin
Journal:  J Otolaryngol Head Neck Surg       Date:  2021-10-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.